Lilly signs licensing deal for early-stage diabetes therapy

Eli Lilly has inked a licensing deal with Taisho Pharmaceutical for a Phase I drug for type 2 diabetes. Lilly gained marketing rights for the drug outside of China and Japan. Financial details were not disclosed.

- read this press release for more